CTOs on the Move

www.biosig.com

www.BioSig

 
BioSig Technologies, Inc. (NASDAQ: BSGM) is a medical device company that is developing a proprietary biomedical signal processing technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Los Angeles-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP™System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.BioSig
  • 12424 Wilshire Boulevard Suite 745
    Los Angeles, CA USA 90025
  • Phone: 310.620.9320

Executives

Name Title Contact Details

Similar Companies

MDG Medical Inc

MDG Medical Inc is a Beachwood, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Element Science

Element Science is a San-Francisco based medical device and digital health start-up that develops lifesaving wearable solutions designed to deliver an outstanding experience.

Applied Laboratories

Applied Laboratories, Inc. is dedicated to providing quality customer services and specializes in meeting client needs and timelines based on its streamlined organizational structure and experienced and knowledgeable staff. We attract our customers with

Xenter

Xenter, Inc. is a privately held company headquartered in Salt Lake City, Utah, that is focused on developing new wireless medical device technologies, innovative digital health tools that will enable individual patients to own and manage their health information, and novel therapeutic drugs utilizing Physical Intelligence™ and patient-supplied data. Xenter has assembled a team of medical scientists, chemical engineers, medical device engineers, researchers, data scientists, and some of the world`s most accomplished entrepreneurs and industry veterans to solve some of the largest challenges in healthcare, medicine and engineering.

Impel NeuroPharma

Impel NeuroPharma is a Seattle-based company developing intranasal drug treatments for central nervous system (CNS) disorders. Impel has developed a novel drug delivery platform, the POD technology, that administers drug to the deep nasal cavity to improve the brain distribution of many drugs. Impel`s proprietary (POD) device technology enables entirely new categories of drugs, including biologics, to be delivered to the central nervous system using a cost-effective, disposable, non-invasive intranasal drug delivery device.